elranatamab
pfizer
['multiplemyeloma', 'pfizer']
we re excited to be at #asco23 sharing data from our robust magnetismm clinical trial program evaluating our investigational bispecific antibody in #multiplemyeloma. learn more: 
The official Twitter channel dedicated to media announcements & investor communications from Pfizer Inc. To see all of our Tweets, please follow @pfizer.